Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

[ad_1] Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training the patient’s immune system to fight the disease. The…








